{"transactions":[{"id":15499,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-08T21:05:54.000Z","date":"2025-11-26","kind":"sale","planned":false,"acquired":false,"shares":6337,"price":10.03,"value":63560.11,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.23. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\").  JJDC is a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4024861,"source":{"system":"sec-edgar","filing":"0001193125-26-007679","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000119312526007679/ownership.xml","form_type":"4/A","original_submission_date":"2025-12-01"}},{"id":15498,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-08T21:05:54.000Z","date":"2025-11-25","kind":"sale","planned":false,"acquired":false,"shares":16000,"price":10.03,"value":160480.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.22. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\").  JJDC is a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4031198,"source":{"system":"sec-edgar","filing":"0001193125-26-007679","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000119312526007679/ownership.xml","form_type":"4/A","original_submission_date":"2025-12-01"}},{"id":16500,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T21:07:15.000Z","date":"2025-11-26","kind":"sale","planned":false,"acquired":false,"shares":6337,"price":10.03,"value":63560.11,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.23. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\").  JJDC is a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4040861,"source":{"system":"sec-edgar","filing":"0001193125-25-303876","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000119312525303876/ownership.xml","form_type":"4"}},{"id":16637,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T17:54:13.000Z","date":"2025-11-24","kind":"sale","planned":false,"acquired":false,"shares":2200,"price":10.06,"value":22132.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.10. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\").  JJDC is a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4047198,"source":{"system":"sec-edgar","filing":"0001193125-25-296047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000119312525296047/ownership.xml","form_type":"4"}},{"id":16636,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T17:54:13.000Z","date":"2025-11-21","kind":"sale","planned":false,"acquired":false,"shares":500,"price":10,"value":5000.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\").  JJDC is a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4049398,"source":{"system":"sec-edgar","filing":"0001193125-25-296047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000119312525296047/ownership.xml","form_type":"4"}},{"id":17262,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T20:07:10.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":10,"value":10000.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. 29 shares were sold at $10.04 and 971 shares were sold at $10.00."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\").  JJDC is a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4049898,"source":{"system":"sec-edgar","filing":"0001193125-25-282669","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000119312525282669/ownership.xml","form_type":"4"}},{"id":17425,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-10T20:28:59.000Z","date":"2025-11-07","kind":"sale","planned":false,"acquired":false,"shares":200,"price":10,"value":2000.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\").  JJDC is a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4050898,"source":{"system":"sec-edgar","filing":"0001193125-25-274067","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000119312525274067/ownership.xml","form_type":"4"}},{"id":17424,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-10T20:28:59.000Z","date":"2025-11-06","kind":"sale","planned":false,"acquired":false,"shares":52332,"price":10.21,"value":534309.72,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.49. The Reporting Persons undertake to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\").  JJDC is a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4051098,"source":{"system":"sec-edgar","filing":"0001193125-25-274067","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000119312525274067/ownership.xml","form_type":"4"}},{"id":43871,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":false,"shares":79,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"1,185 options previously reported as issued and held by JJDC were previously canceled by the Issuer for no value."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":0,"derivative":{"exercise_price":5.141,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":79},"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":33,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43870,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":false,"shares":252,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"506 options previously reported as issued and held by JJDC were previously canceled by the Issuer for no value."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":0,"derivative":{"exercise_price":3.955,"expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":252},"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":32,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43869,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":false,"shares":142,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":0,"derivative":{"exercise_price":1.186,"expiration_date":"2028-11-28","underlying":"Common Stock","underlying_shares":142},"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":31,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43868,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":false,"shares":442,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"316 options previously reported as issued and held by JJDC were previously canceled by the Issuer for no value."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":0,"derivative":{"exercise_price":1.186,"expiration_date":"2028-11-28","underlying":"Common Stock","underlying_shares":442},"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43867,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":0,"derivative":{"exercise_price":0.237,"expiration_date":"2028-02-15","underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43866,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":false,"shares":584,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"174 options previously reported as issued and held by JJDC were previously canceled by the Issuer for no value."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":0,"derivative":{"exercise_price":0.237,"expiration_date":"2028-02-15","underlying":"Common Stock","underlying_shares":584},"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43865,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":false,"shares":489,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":0,"derivative":{"exercise_price":0.237,"expiration_date":"2027-02-01","underlying":"Common Stock","underlying_shares":489},"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43864,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":false,"shares":758,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":0,"derivative":{"exercise_price":0.237,"expiration_date":"2027-02-01","underlying":"Common Stock","underlying_shares":758},"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43863,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":false,"shares":85,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":0,"derivative":{"exercise_price":0.237,"expiration_date":"2025-11-09","underlying":"Common Stock","underlying_shares":85},"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43862,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":false,"shares":23,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":0,"derivative":{"exercise_price":0.237,"expiration_date":"2025-08-06","underlying":"Common Stock","underlying_shares":23},"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43861,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":false,"shares":71,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":0,"derivative":{"exercise_price":0.237,"expiration_date":"2025-08-06","underlying":"Common Stock","underlying_shares":71},"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43860,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":false,"shares":118,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":0,"derivative":{"exercise_price":0.237,"expiration_date":"2025-08-06","underlying":"Common Stock","underlying_shares":118},"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43859,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":false,"shares":165,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":0,"derivative":{"exercise_price":0.237,"expiration_date":"2025-08-06","underlying":"Common Stock","underlying_shares":165},"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43858,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":false,"shares":189,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":0,"derivative":{"exercise_price":0.237,"expiration_date":"2025-08-06","underlying":"Common Stock","underlying_shares":189},"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43857,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":false,"shares":158,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":0,"derivative":{"exercise_price":0.237,"expiration_date":"2024-11-18","underlying":"Common Stock","underlying_shares":158},"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43856,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-16","kind":"other","planned":false,"acquired":false,"shares":607225,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Warrant became exercisable for Common Stock upon the closing of the Issuer's initial public offering and was to expire on the earlier of (i) an acquisition or asset transfer involving the Issuer or (ii) 180 days after receipt of the data from the post-market stage of the Issuer's BeAT-HF pivotal trial."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Warrant became exercisable for Common Stock upon the closing of the Issuer's initial public offering and was to expire on the earlier of (i) an acquisition or asset transfer involving the Issuer or (ii) 180 days after receipt of the data from the post-market stage of the Issuer's BeAT-HF pivotal trial."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Warrant was transferred to JJDC from Biosense Webster, Inc., also a wholly-owned subsidiary of Johnson & Johnson, on February 14, 2024."}],"balance_after":0,"derivative":{"exercise_price":0.158,"underlying":"Common Stock","underlying_shares":607225},"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43855,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":true,"shares":79,"price":5.141,"value":406.139,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4103430,"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43854,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":true,"shares":252,"price":3.955,"value":996.66,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4103351,"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43853,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":true,"shares":142,"price":1.186,"value":168.412,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4103099,"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43852,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":true,"shares":442,"price":1.186,"value":524.212,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4102957,"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43851,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":true,"shares":300,"price":0.237,"value":71.1,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4102515,"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43850,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":true,"shares":584,"price":0.237,"value":138.408,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4102215,"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43849,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":true,"shares":489,"price":0.237,"value":115.893,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4101631,"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43848,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":true,"shares":758,"price":0.237,"value":179.646,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4101142,"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43847,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":true,"shares":85,"price":0.237,"value":20.145,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4100384,"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43846,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":true,"shares":23,"price":0.237,"value":5.451,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4100299,"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43845,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":true,"shares":71,"price":0.237,"value":16.827,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4100276,"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43844,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":true,"shares":118,"price":0.237,"value":27.966,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4100205,"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43843,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":true,"shares":165,"price":0.237,"value":39.105,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4100087,"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43842,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":true,"shares":189,"price":0.237,"value":44.793,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4099922,"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43841,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":true,"shares":158,"price":0.237,"value":37.446,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4099733,"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43840,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-16","kind":"sale","planned":false,"acquired":false,"shares":3725,"price":25.81,"value":96142.25,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 16, 2024, JJDC exercised the Warrant to purchase 607,725 shares of Common Stock and paid the exercise price (adjusted per the net exercise terms of the Warrant) on a cashless basis, resulting in the withholding of 3,725 of the Warrant shares to pay the exercise price and issuance to JJDC of the remaining 604,000 shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4099575,"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":43839,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T20:42:31.000Z","date":"2024-02-16","kind":"other","planned":false,"acquired":true,"shares":607725,"price":0.158,"value":96020.55,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. (\"JJDC\"), a wholly-owned subsidiary of Johnson & Johnson."}],"balance_after":4103300,"source":{"system":"sec-edgar","filing":"0000950170-24-027095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/ownership.xml","form_type":"4"}},{"id":53135,"issuer":{"id":3098,"kind":"organization","name":"Kenvue Inc.","symbol":"KVUE"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-08-25T20:53:18.000Z","date":"2023-08-23","kind":"other","planned":false,"acquired":false,"shares":1533830450,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Johnson & Johnson disposed of 1,533,830,450 shares of Issuer common stock in exchange for 190,955,436 shares of Johnson & Johnson common stock pursuant to a registered exchange offer to holders of shares of Johnson & Johnson common stock. The final exchange ratio was 8.0324 shares of Issuer common stock per share of Johnson & Johnson common stock accepted in the exchange offer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Johnson & Johnson disposed of 1,533,830,450 shares of Issuer common stock in exchange for 190,955,436 shares of Johnson & Johnson common stock pursuant to a registered exchange offer to holders of shares of Johnson & Johnson common stock. The final exchange ratio was 8.0324 shares of Issuer common stock per share of Johnson & Johnson common stock accepted in the exchange offer."}],"balance_after":182329550,"source":{"system":"sec-edgar","filing":"0001628280-23-030660","document":"wk-form4_1692996787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000162828023030660/wk-form4_1692996787.xml","form_type":"4"}},{"id":84954,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series G Preferred Stock","published_at":"2021-07-02T20:59:47.000Z","date":"2021-07-02","kind":"exercise","acquired":false,"shares":48068690,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration.  The preferred stock had no expiration date. Shares of Series D-2 Preferred Stock, Series E-2 Preferred Stock and Series F-2 Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.025857287 and shares of Series G Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.0632143218 (in each case, subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration.  The preferred stock had no expiration date. Shares of Series D-2 Preferred Stock, Series E-2 Preferred Stock and Series F-2 Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.025857287 and shares of Series G Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.0632143218 (in each case, subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration.  The preferred stock had no expiration date. Shares of Series D-2 Preferred Stock, Series E-2 Preferred Stock and Series F-2 Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.025857287 and shares of Series G Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.0632143218 (in each case, subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3038630},"source":{"system":"sec-edgar","filing":"0000904454-21-000576","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445421000576/edgar.xml","form_type":"4"}},{"id":84953,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F-2 Preferred Stock","published_at":"2021-07-02T20:59:47.000Z","date":"2021-07-02","kind":"exercise","acquired":false,"shares":7587828,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration.  The preferred stock had no expiration date. Shares of Series D-2 Preferred Stock, Series E-2 Preferred Stock and Series F-2 Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.025857287 and shares of Series G Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.0632143218 (in each case, subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration.  The preferred stock had no expiration date. Shares of Series D-2 Preferred Stock, Series E-2 Preferred Stock and Series F-2 Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.025857287 and shares of Series G Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.0632143218 (in each case, subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration.  The preferred stock had no expiration date. Shares of Series D-2 Preferred Stock, Series E-2 Preferred Stock and Series F-2 Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.025857287 and shares of Series G Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.0632143218 (in each case, subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":191864},"source":{"system":"sec-edgar","filing":"0000904454-21-000576","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445421000576/edgar.xml","form_type":"4"}},{"id":84952,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E-2 Preferred Stock","published_at":"2021-07-02T20:59:47.000Z","date":"2021-07-02","kind":"exercise","acquired":false,"shares":6451188,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration.  The preferred stock had no expiration date. Shares of Series D-2 Preferred Stock, Series E-2 Preferred Stock and Series F-2 Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.025857287 and shares of Series G Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.0632143218 (in each case, subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration.  The preferred stock had no expiration date. Shares of Series D-2 Preferred Stock, Series E-2 Preferred Stock and Series F-2 Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.025857287 and shares of Series G Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.0632143218 (in each case, subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration.  The preferred stock had no expiration date. Shares of Series D-2 Preferred Stock, Series E-2 Preferred Stock and Series F-2 Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.025857287 and shares of Series G Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.0632143218 (in each case, subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":163123},"source":{"system":"sec-edgar","filing":"0000904454-21-000576","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445421000576/edgar.xml","form_type":"4"}},{"id":84951,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D-2 Preferred Stock","published_at":"2021-07-02T20:59:47.000Z","date":"2021-07-02","kind":"exercise","acquired":false,"shares":4032259,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration.  The preferred stock had no expiration date. Shares of Series D-2 Preferred Stock, Series E-2 Preferred Stock and Series F-2 Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.025857287 and shares of Series G Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.0632143218 (in each case, subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration.  The preferred stock had no expiration date. Shares of Series D-2 Preferred Stock, Series E-2 Preferred Stock and Series F-2 Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.025857287 and shares of Series G Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.0632143218 (in each case, subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration.  The preferred stock had no expiration date. Shares of Series D-2 Preferred Stock, Series E-2 Preferred Stock and Series F-2 Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.025857287 and shares of Series G Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.0632143218 (in each case, subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":101958},"source":{"system":"sec-edgar","filing":"0000904454-21-000576","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445421000576/edgar.xml","form_type":"4"}},{"id":84950,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T20:59:47.000Z","date":"2021-07-02","kind":"exercise","acquired":true,"shares":3495575,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration.  The preferred stock had no expiration date. Shares of Series D-2 Preferred Stock, Series E-2 Preferred Stock and Series F-2 Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.025857287 and shares of Series G Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.0632143218 (in each case, subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":3495575,"source":{"system":"sec-edgar","filing":"0000904454-21-000576","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445421000576/edgar.xml","form_type":"4"}},{"id":103591,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to purchase Common Shares","published_at":"2020-07-02T20:58:57.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":89118,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Upon the closing of the Issuer's initial public offering, the Warrants to purchase Class B Preferred Shares converted to Warrants to purchase Common Shares at an exercise price of $8.10 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the closing of the Issuer's initial public offering, the Warrants to purchase Class B Preferred Shares converted to Warrants to purchase Common Shares at an exercise price of $8.10 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Upon the closing of the Issuer's initial public offering, the Warrants to purchase Class B Preferred Shares converted to Warrants to purchase Common Shares at an exercise price of $8.10 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":89118,"derivative":{"underlying":"Common Shares","underlying_shares":89118},"source":{"system":"sec-edgar","filing":"0000904454-20-000426","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445420000426/edgar.xml","form_type":"4"}},{"id":103590,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to purchase Class B Preferred Shares","published_at":"2020-07-02T20:58:57.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":475802,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Upon the closing of the Issuer's initial public offering, the Warrants to purchase Class B Preferred Shares converted to Warrants to purchase Common Shares at an exercise price of $8.10 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the closing of the Issuer's initial public offering, the Warrants to purchase Class B Preferred Shares converted to Warrants to purchase Common Shares at an exercise price of $8.10 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Upon the closing of the Issuer's initial public offering, the Warrants to purchase Class B Preferred Shares converted to Warrants to purchase Common Shares at an exercise price of $8.10 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Class B Preferred Shares","underlying_shares":475802},"source":{"system":"sec-edgar","filing":"0000904454-20-000426","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445420000426/edgar.xml","form_type":"4"}},{"id":103589,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Preferred Shares","published_at":"2020-07-02T20:58:57.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":5059460,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class A Preferred Shares and Class B Preferred Shares automatically converted into Common Shares on a one-for-5.339 basis upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class A Preferred Shares and Class B Preferred Shares automatically converted into Common Shares on a one-for-5.339 basis upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class A Preferred Shares and Class B Preferred Shares automatically converted into Common Shares on a one-for-5.339 basis upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":947640},"source":{"system":"sec-edgar","filing":"0000904454-20-000426","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445420000426/edgar.xml","form_type":"4"}},{"id":103588,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Preferred Shares","published_at":"2020-07-02T20:58:57.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":10666667,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class A Preferred Shares and Class B Preferred Shares automatically converted into Common Shares on a one-for-5.339 basis upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class A Preferred Shares and Class B Preferred Shares automatically converted into Common Shares on a one-for-5.339 basis upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class A Preferred Shares and Class B Preferred Shares automatically converted into Common Shares on a one-for-5.339 basis upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":1997876},"source":{"system":"sec-edgar","filing":"0000904454-20-000426","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445420000426/edgar.xml","form_type":"4"}},{"id":103587,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2020-07-02T20:58:57.000Z","date":"2020-06-30","kind":"purchase","acquired":true,"shares":725000,"price":17,"value":12325000.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":3670516,"source":{"system":"sec-edgar","filing":"0000904454-20-000426","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445420000426/edgar.xml","form_type":"4"}},{"id":103586,"issuer":{"id":11851,"kind":"organization","name":"Fusion Pharmaceuticals Inc.","symbol":"FUSN"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2020-07-02T20:58:57.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":2945516,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class A Preferred Shares and Class B Preferred Shares automatically converted into Common Shares on a one-for-5.339 basis upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":2945516,"source":{"system":"sec-edgar","filing":"0000904454-20-000426","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445420000426/edgar.xml","form_type":"4"}},{"id":126763,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2018-07-20T14:11:13.000Z","date":"2018-07-19","kind":"exercise","acquired":false,"shares":2400000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Preferred Stock had no expiration date and was automatically converted into shares of Common Stock on a 1-1 basis, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Stock had no expiration date and was automatically converted into shares of Common Stock on a 1-1 basis, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Preferred Stock had no expiration date and was automatically converted into shares of Common Stock on a 1-1 basis, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2400000},"source":{"system":"sec-edgar","filing":"0000904454-18-000479","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445418000479/edgar.xml","form_type":"4"}},{"id":126762,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-07-20T14:11:13.000Z","date":"2018-07-19","kind":"exercise","acquired":true,"shares":2400000,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock had no expiration date and was automatically converted into shares of Common Stock on a 1-1 basis, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":2400000,"source":{"system":"sec-edgar","filing":"0000904454-18-000479","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445418000479/edgar.xml","form_type":"4"}},{"id":129192,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Preferred Stock","published_at":"2018-05-07T20:50:09.000Z","date":"2018-05-07","kind":"exercise","acquired":false,"shares":248631,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares of Series E and Series F Convertible Preferred Stock have no expiration date and were automatically converted into shares of Common Stock for no additional consideration immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Shares of Series F Convertible Preferred Stock converted into shares of Common Stock at a 1-for-0.1504 conversion rate."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares of Series E and Series F Convertible Preferred Stock have no expiration date and were automatically converted into shares of Common Stock for no additional consideration immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares of Series E and Series F Convertible Preferred Stock have no expiration date and were automatically converted into shares of Common Stock for no additional consideration immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Shares of Series F Convertible Preferred Stock converted into shares of Common Stock at a 1-for-0.1504 conversion rate."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":37388},"source":{"system":"sec-edgar","filing":"0000904454-18-000335","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445418000335/edgar.xml","form_type":"4"}},{"id":129191,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Stock","published_at":"2018-05-07T20:50:09.000Z","date":"2018-05-07","kind":"exercise","acquired":false,"shares":1145038,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares of Series E and Series F Convertible Preferred Stock have no expiration date and were automatically converted into shares of Common Stock for no additional consideration immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Shares of Series E Convertible Preferred Stock converted into shares of Common Stock at a 1-for-0.1728 conversion rate."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares of Series E and Series F Convertible Preferred Stock have no expiration date and were automatically converted into shares of Common Stock for no additional consideration immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares of Series E and Series F Convertible Preferred Stock have no expiration date and were automatically converted into shares of Common Stock for no additional consideration immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Shares of Series E Convertible Preferred Stock converted into shares of Common Stock at a 1-for-0.1728 conversion rate."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":197863},"source":{"system":"sec-edgar","filing":"0000904454-18-000335","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445418000335/edgar.xml","form_type":"4"}},{"id":129190,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-07T20:50:09.000Z","date":"2018-05-07","kind":"exercise","acquired":true,"shares":37388,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of Series E and Series F Convertible Preferred Stock have no expiration date and were automatically converted into shares of Common Stock for no additional consideration immediately prior to the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series F Convertible Preferred Stock converted into shares of Common Stock at a 1-for-0.1504 conversion rate."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":235251,"source":{"system":"sec-edgar","filing":"0000904454-18-000335","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445418000335/edgar.xml","form_type":"4"}},{"id":129189,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-07T20:50:09.000Z","date":"2018-05-07","kind":"exercise","acquired":true,"shares":197863,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of Series E and Series F Convertible Preferred Stock have no expiration date and were automatically converted into shares of Common Stock for no additional consideration immediately prior to the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares of Series E Convertible Preferred Stock converted into shares of Common Stock at a 1-for-0.1728 conversion rate."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":197863,"source":{"system":"sec-edgar","filing":"0000904454-18-000335","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445418000335/edgar.xml","form_type":"4"}},{"id":135067,"issuer":{"id":12234,"kind":"organization","name":"ACHILLION PHARMACEUTICALS INC","symbol":"ACHN"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-11-22T16:44:05.000Z","date":"2017-11-20","kind":"sale","acquired":false,"shares":18367346,"price":2.75,"value":50510201.5,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-17-000692","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445417000692/edgar.xml","form_type":"4"}},{"id":137085,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-14T20:33:01.000Z","date":"2017-08-29","kind":"other","acquired":false,"shares":3892256,"price":0.0001,"value":389.2256,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were repurchased by the Issuer at their par value in connection with the amendment of a co-development and license agreement between the Issuer and an affiliate of Johnson & Johnson Innovation - JJDC, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were repurchased by the Issuer at their par value in connection with the amendment of a co-development and license agreement between the Issuer and an affiliate of Johnson & Johnson Innovation - JJDC, Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported as being indirectly beneficially owned by the Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-17-000612","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445417000612/edgar.xml","form_type":"4"}},{"id":149690,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2016-08-18T21:11:34.000Z","date":"2016-08-16","kind":"exercise","acquired":false,"shares":13054830,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock and Series C Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-14.5 basis at the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock and Series C Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-14.5 basis at the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock and Series C Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-14.5 basis at the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The number of shares of Common Stock reflects a 1-for-14.5 reverse stock split, which became effective on August 1, 2016.   Pursuant to the reverse stock split, every 14.5 shares of Series B Preferred Stock and Series C Preferred Stock converted into one share of Common Stock at the closing of the Issuer's initial public offering, for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":900333},"source":{"system":"sec-edgar","filing":"0000904454-16-001373","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445416001373/edgar.xml","form_type":"4"}},{"id":149689,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2016-08-18T21:11:34.000Z","date":"2016-08-16","kind":"exercise","acquired":false,"shares":14000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock and Series C Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-14.5 basis at the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock and Series C Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-14.5 basis at the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock and Series C Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-14.5 basis at the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The number of shares of Common Stock reflects a 1-for-14.5 reverse stock split, which became effective on August 1, 2016.   Pursuant to the reverse stock split, every 14.5 shares of Series B Preferred Stock and Series C Preferred Stock converted into one share of Common Stock at the closing of the Issuer's initial public offering, for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":965517},"source":{"system":"sec-edgar","filing":"0000904454-16-001373","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445416001373/edgar.xml","form_type":"4"}},{"id":149688,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-08-18T21:11:34.000Z","date":"2016-08-16","kind":"purchase","acquired":true,"shares":583333,"price":12,"value":6999996.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":2449183,"source":{"system":"sec-edgar","filing":"0000904454-16-001373","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445416001373/edgar.xml","form_type":"4"}},{"id":149687,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-08-18T21:11:34.000Z","date":"2016-08-16","kind":"exercise","acquired":true,"shares":900333,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The number of shares of Common Stock reflects a 1-for-14.5 reverse stock split, which became effective on August 1, 2016.   Pursuant to the reverse stock split, every 14.5 shares of Series B Preferred Stock and Series C Preferred Stock converted into one share of Common Stock at the closing of the Issuer's initial public offering, for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock and Series C Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-14.5 basis at the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":1865850,"source":{"system":"sec-edgar","filing":"0000904454-16-001373","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445416001373/edgar.xml","form_type":"4"}},{"id":149686,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-08-18T21:11:34.000Z","date":"2016-08-16","kind":"exercise","acquired":true,"shares":965517,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The number of shares of Common Stock reflects a 1-for-14.5 reverse stock split, which became effective on August 1, 2016.   Pursuant to the reverse stock split, every 14.5 shares of Series B Preferred Stock and Series C Preferred Stock converted into one share of Common Stock at the closing of the Issuer's initial public offering, for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock and Series C Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-14.5 basis at the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":965517,"source":{"system":"sec-edgar","filing":"0000904454-16-001373","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445416001373/edgar.xml","form_type":"4"}},{"id":156338,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-02-12T16:54:56.000Z","date":"2015-03-18","kind":"purchase","acquired":true,"shares":607903,"price":4.93,"value":2996961.79,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owed subsidiary of the Reporting Person."}],"balance_after":3892256,"source":{"system":"sec-edgar","filing":"0000904454-16-000987","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445416000987/edgar.xml","form_type":"5"}},{"id":156339,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-02-12T16:48:56.000Z","date":"2015-06-08","kind":"sale","acquired":false,"shares":1010265,"price":48,"value":48492720.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owed subsidiary of the Reporting Person."}],"balance_after":2066740,"source":{"system":"sec-edgar","filing":"0000904454-16-000985","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445416000985/edgar.xml","form_type":"5"}},{"id":161859,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2015-08-12T16:24:38.000Z","date":"2015-08-11","kind":"sale","acquired":false,"shares":1283366,"price":20.74,"value":26617010.84,"ownership":{"direct":false,"nature":"Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $15.55 to $30.00.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person.  Johnson & Johnson Development Corporation changed its name to Johnson & Johnson Innovation - JJDC, Inc. on November 3, 2014."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0000904454-15-000512","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445415000512/edgar.xml","form_type":"4"}},{"id":161858,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2015-08-12T16:24:38.000Z","date":"2015-08-10","kind":"sale","acquired":false,"shares":231455,"price":31.66,"value":7327865.3,"ownership":{"direct":false,"nature":"Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $20.00 to $41.50.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person.  Johnson & Johnson Development Corporation changed its name to Johnson & Johnson Innovation - JJDC, Inc. on November 3, 2014."}],"balance_after":1383366,"source":{"system":"sec-edgar","filing":"0000904454-15-000512","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445415000512/edgar.xml","form_type":"4"}},{"id":163410,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2015-06-08T20:40:28.000Z","date":"2015-06-08","kind":"sale","acquired":false,"shares":1010265,"price":47.94,"value":48432104.1,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the public offering price of $51.00 per share, less the underwriter's discount of $3.06 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person (formerly known as Johnson & Johnson Development Corporation)."}],"balance_after":2066740,"source":{"system":"sec-edgar","filing":"0001144204-15-036056","document":"v412478_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000114420415036056/v412478_4.xml","form_type":"4"}},{"id":165530,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2015-03-17T22:43:01.000Z","date":"2015-03-13","kind":"purchase","acquired":true,"shares":607903,"price":0.125,"value":75987.875,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation- JJDC, Inc."},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The transaction is subject to customary closing conditions and is expected to close on or about 03/18/2015."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction is subject to customary closing conditions and is expected to close on or about 03/18/2015."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person (formerly known as Johnson & Johnson Development Corporation)."}],"balance_after":607903,"derivative":{"exercise_price":5.772,"exercise_date":"2015-03-18","expiration_date":"2017-03-18","underlying":"Common Stock","underlying_shares":607903},"source":{"system":"sec-edgar","filing":"0001144204-15-016825","document":"v404607_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000114420415016825/v404607_4.xml","form_type":"4"}},{"id":165529,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"Johnson & Johnson Innovation - JJDC, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2015-03-17T22:43:01.000Z","date":"2015-03-13","kind":"purchase","acquired":true,"shares":607903,"price":4.81,"value":2924013.43,"ownership":{"direct":false,"nature":"By Johnson & Johnson Innovation - JJDC, Inc."},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The transaction is subject to customary closing conditions and is expected to close on or about 03/18/2015."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 3,892,256 shares of Common Stock and 607,903 shares of Common Stock underlying immediately exercisable warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person (formerly known as Johnson & Johnson Development Corporation)."}],"balance_after":4500159,"source":{"system":"sec-edgar","filing":"0001144204-15-016825","document":"v404607_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000114420415016825/v404607_4.xml","form_type":"4"}},{"id":167252,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2015-02-03T17:05:14.000Z","date":"2014-03-12","kind":"exercise","acquired":false,"shares":379543,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Development Corporation"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Upon the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Upon the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":379543},"source":{"system":"sec-edgar","filing":"0000904454-15-000039","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445415000039/edgar.xml","form_type":"4/A","original_submission_date":"2014-03-12"}},{"id":167251,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2015-02-03T17:05:14.000Z","date":"2014-03-12","kind":"exercise","acquired":false,"shares":292532,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Development Corporation"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Upon the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Upon the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":292532},"source":{"system":"sec-edgar","filing":"0000904454-15-000039","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445415000039/edgar.xml","form_type":"4/A","original_submission_date":"2014-03-12"}},{"id":167250,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2015-02-03T17:05:14.000Z","date":"2014-03-12","kind":"exercise","acquired":false,"shares":293884,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Development Corporation"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Upon the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Upon the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":293884},"source":{"system":"sec-edgar","filing":"0000904454-15-000039","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445415000039/edgar.xml","form_type":"4/A","original_submission_date":"2014-03-12"}},{"id":167249,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 Preferred Stock","published_at":"2015-02-03T17:05:14.000Z","date":"2014-03-12","kind":"exercise","acquired":false,"shares":170454,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Development Corporation"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Upon the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Upon the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":170454},"source":{"system":"sec-edgar","filing":"0000904454-15-000039","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445415000039/edgar.xml","form_type":"4/A","original_submission_date":"2014-03-12"}},{"id":167248,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2015-02-03T17:05:14.000Z","date":"2014-03-12","kind":"exercise","acquired":false,"shares":255681,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Development Corporation"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Upon the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Upon the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":255681},"source":{"system":"sec-edgar","filing":"0000904454-15-000039","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445415000039/edgar.xml","form_type":"4/A","original_submission_date":"2014-03-12"}},{"id":167247,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2015-02-03T17:05:14.000Z","date":"2014-03-12","kind":"purchase","acquired":true,"shares":272727,"price":11,"value":2999997.0,"ownership":{"direct":false,"nature":"Johnson & Johnson Development Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":1664821,"source":{"system":"sec-edgar","filing":"0000904454-15-000039","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445415000039/edgar.xml","form_type":"4/A","original_submission_date":"2014-03-12"}},{"id":167246,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2015-02-03T17:05:14.000Z","date":"2014-03-12","kind":"exercise","acquired":true,"shares":1392094,"ownership":{"direct":false,"nature":"Johnson & Johnson Development Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":1392094,"source":{"system":"sec-edgar","filing":"0000904454-15-000039","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445415000039/edgar.xml","form_type":"4/A","original_submission_date":"2014-03-12"}},{"id":168290,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2014-12-18T15:43:17.000Z","date":"2014-12-17","kind":"sale","acquired":false,"shares":1593,"price":7.58,"value":12074.94,"ownership":{"direct":false,"nature":"Johnson & Johnson Development Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.52 to $7.75. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":1342094,"source":{"system":"sec-edgar","filing":"0000904454-14-000809","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000809/edgar.xml","form_type":"4"}},{"id":168289,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2014-12-18T15:43:17.000Z","date":"2014-12-16","kind":"sale","acquired":false,"shares":6507,"price":7.63,"value":49648.41,"ownership":{"direct":false,"nature":"Johnson & Johnson Development Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.60 to $7.70. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":1343687,"source":{"system":"sec-edgar","filing":"0000904454-14-000809","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000809/edgar.xml","form_type":"4"}},{"id":168353,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2014-12-16T01:48:31.000Z","date":"2014-12-12","kind":"sale","acquired":false,"shares":3645,"price":7.51,"value":27373.95,"ownership":{"direct":false,"nature":"Johnson & Johnson Development Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.56. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":1350194,"source":{"system":"sec-edgar","filing":"0000904454-14-000805","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000805/edgar.xml","form_type":"4"}},{"id":168352,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2014-12-16T01:48:31.000Z","date":"2014-12-11","kind":"sale","acquired":false,"shares":1355,"price":7.5,"value":10162.5,"ownership":{"direct":false,"nature":"Johnson & Johnson Development Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.48 to $7.51. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":1353839,"source":{"system":"sec-edgar","filing":"0000904454-14-000805","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000805/edgar.xml","form_type":"4"}},{"id":168419,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2014-12-11T02:13:04.000Z","date":"2014-12-10","kind":"sale","acquired":false,"shares":1300,"price":7.7,"value":10010.0,"ownership":{"direct":false,"nature":"Johnson & Johnson Development Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.70 to $7.73. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":1355194,"source":{"system":"sec-edgar","filing":"0000904454-14-000793","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000793/edgar.xml","form_type":"4"}},{"id":168418,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2014-12-11T02:13:04.000Z","date":"2014-12-09","kind":"sale","acquired":false,"shares":5000,"price":7.73,"value":38650.0,"ownership":{"direct":false,"nature":"Johnson & Johnson Development Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.70 to $7.80. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":1356494,"source":{"system":"sec-edgar","filing":"0000904454-14-000793","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000793/edgar.xml","form_type":"4"}},{"id":168417,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2014-12-11T02:13:04.000Z","date":"2014-12-08","kind":"sale","acquired":false,"shares":2000,"price":7.69,"value":15380.0,"ownership":{"direct":false,"nature":"Johnson & Johnson Development Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.60 to $7.75. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":1361494,"source":{"system":"sec-edgar","filing":"0000904454-14-000793","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000793/edgar.xml","form_type":"4"}},{"id":168458,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2014-12-05T23:57:26.000Z","date":"2014-12-05","kind":"sale","acquired":false,"shares":4200,"price":7.78,"value":32676.0,"ownership":{"direct":false,"nature":"Johnson & Johnson Development Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.75 to $7.84. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":1363494,"source":{"system":"sec-edgar","filing":"0000904454-14-000787","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000787/edgar.xml","form_type":"4"}},{"id":168457,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2014-12-05T23:57:26.000Z","date":"2014-12-04","kind":"sale","acquired":false,"shares":10073,"price":7.76,"value":78166.48,"ownership":{"direct":false,"nature":"Johnson & Johnson Development Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.75 to $7.80. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":1367694,"source":{"system":"sec-edgar","filing":"0000904454-14-000787","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000787/edgar.xml","form_type":"4"}},{"id":168456,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2014-12-05T23:57:26.000Z","date":"2014-12-03","kind":"sale","acquired":false,"shares":1627,"price":7.75,"value":12609.25,"ownership":{"direct":false,"nature":"Johnson & Johnson Development Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":1377767,"source":{"system":"sec-edgar","filing":"0000904454-14-000787","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000787/edgar.xml","form_type":"4"}},{"id":168524,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2014-12-03T19:24:05.000Z","date":"2014-12-01","kind":"sale","acquired":false,"shares":1200,"price":7.54,"value":9048.0,"ownership":{"direct":false,"nature":"Johnson & Johnson Development Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.49 to $7.65. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":1379394,"source":{"system":"sec-edgar","filing":"0000904454-14-000781","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000781/edgar.xml","form_type":"4"}},{"id":168641,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2014-11-26T21:18:02.000Z","date":"2014-11-26","kind":"sale","acquired":false,"shares":500,"price":7.6,"value":3800.0,"ownership":{"direct":false,"nature":"Johnson & Johnson Development Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":1380594,"source":{"system":"sec-edgar","filing":"0000904454-14-000779","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000779/edgar.xml","form_type":"4"}},{"id":168640,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2014-11-26T21:18:02.000Z","date":"2014-11-25","kind":"sale","acquired":false,"shares":1500,"price":7.8,"value":11700.0,"ownership":{"direct":false,"nature":"Johnson & Johnson Development Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.70 to $7.85. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":1381094,"source":{"system":"sec-edgar","filing":"0000904454-14-000779","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000779/edgar.xml","form_type":"4"}},{"id":168713,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2014-11-24T22:45:27.000Z","date":"2014-11-24","kind":"sale","acquired":false,"shares":4000,"price":8.02,"value":32080.0,"ownership":{"direct":false,"nature":"Johnson & Johnson Development Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.05. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":1382594,"source":{"system":"sec-edgar","filing":"0000904454-14-000769","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000769/edgar.xml","form_type":"4"}},{"id":168712,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2014-11-24T22:45:27.000Z","date":"2014-11-21","kind":"sale","acquired":false,"shares":2400,"price":8.25,"value":19800.0,"ownership":{"direct":false,"nature":"Johnson & Johnson Development Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.20 to $8.25. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":1386594,"source":{"system":"sec-edgar","filing":"0000904454-14-000769","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000769/edgar.xml","form_type":"4"}},{"id":168711,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2014-11-24T22:45:27.000Z","date":"2014-11-20","kind":"sale","acquired":false,"shares":3100,"price":8.21,"value":25451.0,"ownership":{"direct":false,"nature":"Johnson & Johnson Development Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.20 to $8.25. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":1388994,"source":{"system":"sec-edgar","filing":"0000904454-14-000769","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000769/edgar.xml","form_type":"4"}},{"id":169093,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2014-11-12T20:06:17.000Z","date":"2014-11-12","kind":"exercise","acquired":false,"shares":246827,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Development Corporation"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Immediately prior to the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately prior to the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Immediately prior to the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":246827},"source":{"system":"sec-edgar","filing":"0000904454-14-000731","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000731/edgar.xml","form_type":"4"}},{"id":169092,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2014-11-12T20:06:17.000Z","date":"2014-11-12","kind":"exercise","acquired":false,"shares":2790178,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Development Corporation"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Immediately prior to the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately prior to the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Immediately prior to the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2790178},"source":{"system":"sec-edgar","filing":"0000904454-14-000731","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000731/edgar.xml","form_type":"4"}},{"id":169091,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2014-11-12T20:06:17.000Z","date":"2014-11-12","kind":"purchase","acquired":true,"shares":40000,"price":18,"value":720000.0,"ownership":{"direct":false,"nature":"By Johnson & Johnson Development Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":3077005,"source":{"system":"sec-edgar","filing":"0000904454-14-000731","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000731/edgar.xml","form_type":"4"}},{"id":169090,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ","position":1,"cik":"0000200406","reported_name":"JOHNSON & JOHNSON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11151,"kind":"organization","name":"Johnson & Johnson Innovation - JJDC, Inc.","position":2,"cik":"0000924020","reported_name":"JOHNSON & JOHNSON DEVELOPMENT CORP ET AL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2014-11-12T20:06:17.000Z","date":"2014-11-12","kind":"exercise","acquired":true,"shares":3037005,"ownership":{"direct":false,"nature":"Johnson & Johnson Development Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Immediately prior to the closing of the Issuer's initial public offering each outstanding share of Preferred Stock automatically converted into Common Stock, on a 1-to-1 basis, for no additional  consideration. There was no expiration applicable to the Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person."}],"balance_after":3037005,"source":{"system":"sec-edgar","filing":"0000904454-14-000731","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000090445414000731/edgar.xml","form_type":"4"}}],"next_cursor":"2014-11-12T20:06:17.000000Z,169090"}